Eli Lilly stock fell 4 percent Monday, but health analysts say there's no immediate cause for concern.
The expansion will allow Eli Lilly to increase the manufacturing of Trulicity, a diabetes product the company launched a couple years ago.
Lilly makes a form of insulin called Humalog, whose list price has doubled since 2011, the lawsuit claims.
Even though a high-profile Alzheimer’s drug failed its most recent trial, the pharma giant is still holding out hope.
Lilly will be trimming workers in its biomedicines sales force starting in 2017.
Lilly will not seek regulatory approval for the drug.
Vermont senator Bernie Sanders and Maryland representative Elijah Cummings criticize three insulin manufacturers for skyrocketing insulin prices.
Indianapolis-based pharmaceutical giant Eli Lilly will have a new CEO in January.
Lilly is already a big contributor to the United Way, but the collaboration announced Thursday will expand that to six countries.
Eli Lilly reported its revenue as $19.96 billion for FY 2015, with a profit of $2.41 billion.